BRIEF-Cortexyme Announces Agreement To Acquire Novosteo

Reuters2022-05-10

May 10 (Reuters) - Cortexyme Inc :

* CORTEXYME ANNOUNCES AGREEMENT TO ACQUIRE NOVOSTEO

* SAYS UPON COMPLETION OF TRANSACTION, NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF COMBINED COMPANY

* NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF COMBINED COMPANY

* UPON CLOSE, CO WILL APPOINT NOVOSTEO EXECUTIVES DIRK THYE AS CHIEF EXECUTIVE OFFICER

* COMPANY PLANS TO OPERATE UNDER NEW NAME - QUINCE THERAPEUTICS INC - AND BEGIN TRADING UNDER TICKER SYMBOL "QNCX"

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2234693244?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-05-10 20:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2234693244","market":"us","top_or_hot":-1,"title":"BRIEF-Cortexyme Announces Agreement To Acquire Novosteo","media":"Reuters","content":"<html><body><p>May 10 (Reuters) - Cortexyme Inc   :</p><p>   * CORTEXYME ANNOUNCES AGREEMENT TO ACQUIRE NOVOSTEO</p><p>   * SAYS UPON COMPLETION OF TRANSACTION, NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF COMBINED COMPANY</p><p>   * NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF COMBINED COMPANY</p><p>   * UPON CLOSE, CO WILL APPOINT NOVOSTEO EXECUTIVES DIRK THYE AS CHIEF EXECUTIVE OFFICER</p><p>   * COMPANY PLANS TO OPERATE UNDER NEW NAME - QUINCE THERAPEUTICS INC - AND BEGIN TRADING UNDER TICKER SYMBOL \"QNCX\"</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Cortexyme Announces Agreement To Acquire Novosteo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Cortexyme Announces Agreement To Acquire Novosteo\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-10 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>May 10 (Reuters) - Cortexyme Inc   :   * CORTEXYME ANNOUNCES AGREEMENT TO ACQUIRE NOVOSTEO   * SAYS UPON COMPLETION OF TRANSACTION, NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF COMBINED ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2234693244","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2234693244","pubTimestamp":1652184576,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"May 10 (Reuters) - Cortexyme Inc   :   * CORTEXYME ANNOUNCES AGREEMENT TO ACQUIRE NOVOSTEO   * SAYS ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SANA":"Sana Biotechnology, Inc.","ONTF":"ON24, Inc.","BK4196":"保健护理服务","CGEM":"Cullinan Therapeutics","BK4139":"生物科技","APR":"Apria, Inc.","BK4023":"应用软件","LHDX":"Lucira Health, Inc.","BK4007":"制药","LABP":"Landos Biopharma, Inc."},"translate_title":"简讯-Cortexyme宣布同意收购Novosteo","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRTX":0.9,"APR":0.77,"CGEM":0.77,"LABP":0.77,"LHDX":0.77,"ONTF":0.77,"SANA":0.77},"content_text":"May 10 (Reuters) - Cortexyme Inc   :   * CORTEXYME ANNOUNCES AGREEMENT TO ACQUIRE NOVOSTEO   * SAYS UPON COMPLETION OF TRANSACTION, NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF COMBINED COMPANY   * NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF COMBINED COMPANY   * UPON CLOSE, CO WILL APPOINT NOVOSTEO EXECUTIVES DIRK THYE AS CHIEF EXECUTIVE OFFICER   * COMPANY PLANS TO OPERATE UNDER NEW NAME - QUINCE THERAPEUTICS INC - AND BEGIN TRADING UNDER TICKER SYMBOL \"QNCX\"Source text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2234693244"}